Krishna Illa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Krishna illa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Krishna Illa Today - Breaking & Trending Today

Maruti Suzuki plans to re-enter diesel segment next year : Bulletin: Business Today


Loading the player.
Foreign banks, capital from abroad can remedy India s bad debt: Abhijit Banerjee
As discussion continues whether private players should be allowed in the Indian banking space, Nobel laureate Abhijit Banerjee pointed out how foreign participation can save the bleeding sector. Banerjee said that Indian banks need a huge capital infusion to stay viable that can come easily from foreign sources. Banerjee noted that once we take on the view that the banking sector needs more private ownership, restricting it to Indian ownership will be a mistake.
Average time spent on smartphone up 25% to almost 7 hours amid pandemic: Vivo report ....

United Kingdom , Maruti Suzuki , Abhijit Banerjee , Krishna Illa , Mexican Federal Commission For The Protection , Maruti Suzuki India , Bharat Biotech , Mexican Federal Commission , Sanitary Risk , ஒன்றுபட்டது கிஂக்டம் , மாருதி ஸஸூகீ , கிருஷ்ணா இல்ல , மெக்ஸிகன் கூட்டாட்சியின் தரகு க்கு தி ப்ரொடெக்ஶந் , மாருதி ஸஸூகீ இந்தியா , பாரத் பயோடெக் , மெக்ஸிகன் கூட்டாட்சியின் தரகு , சுகாதார ஆபத்து ,

COVID-19 vaccine: 'Covaxin' is safe, developed on time-proven tech, says Bharat Biotech MD


COVID-19 vaccine: Covaxin is safe, developed on time-proven tech, says Bharat Biotech MD
An expert committee of the Central Drugs Standard Control Organisation (CDSCO) sought additional safety and efficacy data for COVID-19 vaccine candidates of Bharat Biotech after deliberating upon its applications seeking emergency use authorisation for the shots
BusinessToday.In | December 13, 2020 | Updated 15:58 IST
Covaxin has been developed in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV)
India s first indigenous coronavirus vaccine, Covaxin, is safe and built on a time-proven technology, claimed Bharat Biotech s chairman and managing director Krishna Illa.
Bharat Biotech, which is conducting a Phase-3 clinical trial of Covaxin in over 25 centres across India, applied to the drug regulator seeking emergency authorisation for its COVID-19 vaccine last week based on Phase 1 and 2 trial data. ....

Atma Nirbhar , Krishna Illa , National Institute Of Virology , Indian Council Of Medical Research , Central Drugs Standard Control Organisation , Bharat Biotech , Indian Council , Medical Research , National Institute , India Atmanirbhar , ஆத்மா நிர்பர் , கிருஷ்ணா இல்ல , தேசிய நிறுவனம் ஆஃப் வைராலஜி , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் , பாரத் பயோடெக் , இந்தியன் சபை , மருத்துவ ஆராய்ச்சி , தேசிய நிறுவனம் ,